Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Sex steroids affect the MafB gene differently in male and female hamsters.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Woodhouse-Sakati Syndrome can include unique symptoms like liver issues and low growth hormone.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

More research is needed to understand how testosterone is maintained in adult males.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Fat cells are important for tissue repair and stem cell support in various body parts.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.

Gastroparesis can cause persistent TSH elevation in hypothyroidism despite treatment.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Injecting cosyntropin into grizzly bears increases blood cortisol but doesn't change hair cortisol levels.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.